drugset / Trial / NCT04699721
Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the safety and effect of neoadjuvant chemotherapy and immunotherapy combined with probiotics for early resectable NSCLC patients.
Timeline
- Start
- 2020-07-01
- Primary completion
- 2027-09
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bifico | Other / unclassified | 4 unknown | Oral |
| Subject | Carboplatin | Small molecule | 5 unknown | — |
| Subject | Nivolumab | Monoclonal antibody | 4.5 mg/kg | — |
| Subject | Paclitaxel | Small molecule | 260 mg/m2 | — |